Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial
…, JS Barrett, M Haines, JD Doecke… - Official journal of the …, 2011 - journals.lww.com
OBJECTIVES: Despite increased prescription of a gluten-free diet for gastrointestinal symptoms
in individuals who do not have celiac disease, there is minimal evidence that suggests …
in individuals who do not have celiac disease, there is minimal evidence that suggests …
Blood-based protein biomarkers for diagnosis of Alzheimer disease
… Author Contributions: Drs Doecke and Laws contributed equally to this manuscript. Study
concept and design: Doecke, Wilson, Bush, Ellis, Head, Ames, Masters, and Martins. …
concept and design: Doecke, Wilson, Bush, Ellis, Head, Ames, Masters, and Martins. …
Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment
There is no consensus for a blood-based test for the early diagnosis of Alzheimer’s disease (AD).
Expression profiling of small non-coding RNA’s, microRNA (miRNA), has revealed …
Expression profiling of small non-coding RNA’s, microRNA (miRNA), has revealed …
A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes
Diagnosis of the autoimmune disease type 1 diabetes (T1D) is preceded by the appearance
of circulating autoantibodies to pancreatic islets. However, almost nothing is known about …
of circulating autoantibodies to pancreatic islets. However, almost nothing is known about …
Reduced α-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease
Background and aims: Reduced ileal Paneth cell α-defensin expression has been reported
to be associated with Crohn’s disease, especially in patients carrying NOD2 mutations. The …
to be associated with Crohn’s disease, especially in patients carrying NOD2 mutations. The …
Total Aβ42/Aβ40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis
Objective To explore whether the plasma total β-amyloid (Aβ) Aβ 42 /Aβ 40 ratio is a reliable
predictor of the amyloid-PET status by exploring the association between these 2 variables …
predictor of the amyloid-PET status by exploring the association between these 2 variables …
Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET
We fractionated frontal cortical grey matter from human Alzheimer’s disease and control
subjects into four biochemically defined pools that represent four distinct compartments: soluble/…
subjects into four biochemically defined pools that represent four distinct compartments: soluble/…
Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: a cross‐sectional and longitudinal study in the AIBL cohort
… Pratishtha Chatterjee carried out the statistical analyses, data visualization and interpretation,
and James D. Doecke, Abhay K. Singh, and Penghao Wang validated the statistical …
and James D. Doecke, Abhay K. Singh, and Penghao Wang validated the statistical …
Alzheimer's disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies—gains from AIBL and DIAN …
Worldwide there are over 46 million people living with dementia, and this number is expected
to double every 20 years reaching about 131 million by 2050. The cost to the community …
to double every 20 years reaching about 131 million by 2050. The cost to the community …
A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study
Dementia is a global epidemic with Alzheimer’s disease (AD) being the leading cause. Early
identification of patients at risk of developing AD is now becoming an international priority. …
identification of patients at risk of developing AD is now becoming an international priority. …
